Blazar, B R <br/><br/>
Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  Jun 1998 
 - 5355-65 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0022-1767 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Bone Marrow Transplantation--immunology<br/>CD4-Positive T-Lymphocytes--metabolism<br/>CD8-Positive T-Lymphocytes--transplantation<br/>Cell Separation<br/>Cytokines--biosynthesis<br/>Cytotoxicity, Immunologic--drug effects<br/>Female<br/>Graft vs Host Disease--immunology<br/>Histocompatibility Antigens Class II--genetics<br/>Immunosuppressive Agents--administration & dosage<br/>Injections, Intraperitoneal<br/>Leukemia, Myeloid, Acute--immunology<br/>Lymphocyte Activation--drug effects<br/>Lymphocyte Transfusion<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Inbred C57BL<br/>Mice, Transgenic<br/>Polyenes--administration & dosage<br/>Radiation Chimera<br/>Receptors, Antigen, T-Cell, alpha-beta<br/>Sirolimus<br/>T-Lymphocyte Subsets--metabolism<br/>Th1 Cells--immunology<br/>Up-Regulation--drug effects